Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib

Moshe Yair Levy, MD, Lin Xie, MA, MS, Yuexi Wang, Frank Neumann, MD PhD, Shouryadeep Srivastava, MBBS, PhD, Daniel Naranjo, Jing Xu, Qisu Zhang, MPH, Mehul Dalal, PhD

Blood (2019) 134 (Supplement_1): 4751.

https://doi.org/10.1182/blood-2019-129053

Published: 2019

Journal Articles

Real-World Comparisons of Cardiovascular Events between Different Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia

Moshe Yair Levy, MD, Lin Xie, MA, MS, Yuexi Wang, Frank Neumann, MD PhD, Shouryadeep Srivastava, MBBS, PhD, Daniel Naranjo, Qisu Zhang, Mehul Dalal, PhD

Blood (2018) 132 (Supplement 1): 3567.

https://doi.org/10.1182/blood-2018-99-113490

Published: 2018

Journal Articles

Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R 2 ) in the US Medicare Population

Scott Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD

Blood (2017) 130 (Supplement 1): 4706.

https://doi.org/10.1182/blood.V130.Suppl_1.4706.4706

Published: 2017

Journal Articles

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Scott F Huntington, MDMPH, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Michael McGuire, PharmD

Blood (2016) 128 (22): 3574.

https://doi.org/10.1182/blood.V128.22.3574.3574

Published: 2016

Journal Articles

Treatment Patterns Among Newly Diagnosed Multiple Myeloma Patients in the United States Veteran Population (2010-2015)

Kejal Parikh, Shivani Pandya, MS, Safiya Abouzaid, Onur Baser, MS, PhD, Lin Xie, MA, MS, Manali I. Patel, MD MPH, MS

Blood (2016) 128 (22): 5952.

https://doi.org/10.1182/blood.V128.22.5952.5952

Published: 2016

Journal Articles

Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide

Lin Xie, MA, MS, Kejal Parikh, Safiya Abouzaid, Shivani Pandya, MS, Onur Baser, MS, PhD, Manali I. Patel, MD MPH, MS

Blood (2016) 128 (22): 5924.

https://doi.org/10.1182/blood.V128.22.5924.5924

Published: 2016

Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH

Blood (2015) 126 (23): 745.

https://doi.org/10.1182/blood.V126.23.745.745

Published: 2015

NARROW

Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib

Real-World Comparisons of Cardiovascular Events between Different Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia

Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R 2 ) in the US Medicare Population

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Treatment Patterns Among Newly Diagnosed Multiple Myeloma Patients in the United States Veteran Population (2010-2015)

Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Email alerts

ASH Publications

American Society of Hematology

Major Adverse Cardiac, Arterial Occlusive, and Venous Occlusive Events Among Chronic Myeloid Leukemia Patients Prescribed Ponatinib Vs Bosutinib

Real-World Comparisons of Cardiovascular Events between Different Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia

Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R 2 ) in the US Medicare Population

Evaluating the Economic Burden and Health Care Utilization Following First-Line Therapy for Diffuse Large B-Cell Lymphoma Patients in the US Medicare Population

Treatment Patterns Among Newly Diagnosed Multiple Myeloma Patients in the United States Veteran Population (2010-2015)

Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only